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Abstract
Background:  Improvements in genome sequence annotation revealed discrepancies in the
original probeset/gene assignment in Affymetrix microarray and the existence of differences
between annotations and effective alignments of probes and transcription products. In the current
generation of Affymetrix human GeneChips, most probesets include probes matching transcripts
from more than one gene and probes which do not match any transcribed sequence.
Results: We developed a novel set of custom Chip Definition Files (CDF) and the corresponding
Bioconductor libraries for Affymetrix human GeneChips, based on the information contained in
the GeneAnnot database. GeneAnnot-based CDFs are composed of unique custom-probesets,
including only probes matching a single gene.
Conclusion: GeneAnnot-based custom CDFs solve the problem of a reliable reconstruction of
expression levels and eliminate the existence of more than one probeset per gene, which often
leads to discordant expression signals for the same transcript when gene differential expression is
the focus of the analysis. GeneAnnot CDFs are freely distributed and fully compliant with
Affymetrix standards and all available software for gene expression analysis. The CDF libraries are
available from http://www.xlab.unimo.it/GA_CDF, along with supplementary information (CDF
libraries, installation guidelines and R code, CDF statistics, and analysis results).
Background
Affymetrix technology is widely used for the analysis of
transcriptional profiles and most gene expression data
available in public repositories have been produced using
different generations of Affymetrix GeneChips. In this
type of microarrays, the expression signal of each tran-
script is quantified summarizing the intensities of all the
oligonucleotides, i.e. the probes (e.g., 11 or 16), of a
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probeset matching a target gene or transcript. The signal
can be generated using a series of statistical or model-
based algorithms (i.e., MAS5.0, MBEI, RMA, GCRMA,
PLIER, PDNN). Despite the computational differences, all
methods for signal quantification rely on the correspond-
ence between probes and genomic sequences. The
Affymetrix Chip Definition Files (CDFs) encode the phys-
ical design of the microarray and contain the sequence
details to link the oligonucleotide probes of the chip to
the interrogated transcripts. The information of a CDF file
relies so deeply on the genome annotation contained in
the databases that the same name of the chip reflects the
version of the UniGene Build used for probe design (e.g.,
the HG-U133 expression set and the human UniGene
Build 133). The evolution of genome sequence annota-
tion from the time when probesets were designed caused
a massive deviation from the original one-to-one
probeset/transcription locus (i.e. UniGene entry) assign-
ment. Several studies revealed the existence of a consider-
able gap in the correspondence between Affymetrix
probes and probesets with genes and transcripts [1-8].
Affymetrix continuously updates probesets annotations
and redefines the links between probesets and genes indi-
cating the UniGene cluster that contains the probeset rep-
resentative sequences and linking them to the
corresponding EntrezGene ID. Similarly, the Bioconduc-
tor Biocore team quarterly releases CDFs and annotation
libraries at the Bioconductor website, which can be used
for analysis of gene expression data in R environment.
However, these update actions simply affect the qualita-
tive attributes of probesets without any degree of control
on the effective matching between probes and genome
sequences. As such, Dai et al. [6] developed a novel system
for associating probes to genomic information, based on
custom-probesets which are composed of at least four
probes specifically matching the same sequence. Dai and
coworkers defined custom-probesets based on updated
versions of RefSeq, EntrezGene as well as ENSEMBL Gene,
Transcript and Exon entries and generated custom CDFs
for the most popular Affymetrix GeneChips [9]. The
development of custom CDF was shown to deeply
improve the analysis outcome when the focus of the
experiment is the identification of differentially expressed
genes [5,6]. Furthermore, the assembly of Dai et al., based
on different sources of information, provides a set of cus-
tom CDFs useful for different analytical purposes. Never-
theless, in these CDFs a specific probe may be included in
more than one custom-probeset, thus introducing some
uncertainty in the association between probe signal and
overall expression level of corresponding transcripts. As
an example, in version 8 of the RefSeq-based set of human
probesets for the HG-U133A array, 26% of probes are
included in two or more probesets and 48% of probesets
share probes with other probesets.
More recently, Lu et al. [7] developed custom-probesets
definitions for Affymetrix GeneChips based on transcript
sequences from the AceView database. Custom-probesets
defined by Lu et al. are reorganized groups of probes, spe-
cifically matching the same transcript or the same group
of transcript sequences, independently from their original
inclusion in different Affymetrix probesets. Lu et al.
showed that their probesets are able to discriminate
between differential expressions of specific transcript var-
iants. Although addressing the issue of multiple transcript
variants, this approach still present the limitation that
most of the redefined transcript-related probesets match
more than one transcript, thus hampering the discrimina-
tion between differential expression of a specific transcript
variant. In this work we explore the association between
probesets and genes and transcripts and define alternative
Chip Definition Files for Affymetrix 3' expression arrays
with the intent to reduce the impact in signal quantifica-
tion of probes matching more than one gene and/or of
probes which do not match any transcribed gene.
Although there is a growing interest in using microarray
platforms to detect events related to the complexity of
gene structure, e.g., multiple transcripts per gene, alterna-
tive splicing and exon differential expression, the identifi-
cation of differentially expressed genes is still the major
goal of microarray-based expression studies and 3' expres-
sion arrays still represent the most abundant source of
data contained in public repositories. The use of GeneAn-
not CDFs (GA_CDFs) is intended to improve gene-cen-
tered analysis of transcriptional data where the focus is in
the reliable identification of genes, rather than individual
transcripts, that are differentially expressed. Other aspects
related to individual transcript variants, alternative splic-
ing and exon differential expression, although, in princi-
ple, detectable with 3' expression arrays, can be more
efficiently investigated using dedicated technologies such
as Affymetrix genome-wide, whole-transcript coverage
arrays.
Our set of custom CDFs and corresponding Bioconductor
packages (i.e. CDF, probe and annotation libraries) for
Affymetrix human gene chips are based on the GeneAn-
not database which contains the comparison of any
Affymetrix probe with transcript sequences from publicly
available cDNAs, GenBank, RefSeq and Ensembl reposi-
tories [10].
Implementation
GeneAnnot was created as part of the GeneCards human
gene indexing database [11] to explore the many-to-many
relationships between probesets and genes. GeneCards
hierarchically defines a gene based on three major
sources, the HUGO gene nomenclature committee
(HGNC) database [12], Entrez Gene, and Ensembl. Every
gene present in the first source obtains a HGNC symbol,BMC Bioinformatics 2007, 8:446 http://www.biomedcentral.com/1471-2105/8/446
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and is clearly linked to the other two sources. Other genes
obtain their symbol from the other two sources. As such,
GeneCards has an inclusive list of genes from all three
sources, with extensive mutual links and connections to
more than 50 databases. In GeneAnnot, each probe from
Affymetrix probesets is matched with transcript sequences
from GenBank, RefSeq and Ensembl databases, and then
transcripts are linked to GeneCards genes [10].
The novel set of custom GeneChip CDFs, named
GA_CDFs, and the corresponding Bioconductor probe
and annotation libraries, have been designed using Gene-
Annot and GeneCards. GA_CDF files are currently availa-
ble for the human GeneChips HG-U95 set, HG-U133 set
and HG-U133 Plus 2.0, based on GeneAnnot version
1.4a, synchronized with GeneCards Version 2.35.
GA_CDF have been designed using the concept of gene-
related custom-probesets, starting from the subset of
Affymetrix GeneChip probes that matches transcripts spe-
cifically linked to a single GeneCards gene. Probes have
been first aggregated into putative custom-probesets, each
one including only those probes with a unique and exclu-
sive correspondence with a single GeneCardsID. Probe to
sequence correspondence has been quantified allowing a
single mismatch in the comparison between the Affyme-
trix 25-mer and the target sequence [10]. Then, custom-
probesets have been retained and included in the custom
CDF if, and only if, they contained at least 11 probes
(GA11_CDF), i.e. the minimum number of probes in
standard Affymetrix probesets. To evaluate the impact of
the number of probes making up a custom-probeset, all
the analyses have been also performed using an alterna-
tive CDF, GA6_CDF, composed of custom-probesets
including a minimum of 6 probes, selected with the same
criteria adopted for GA11_CDF. Probeset names were gen-
erated adding the suffix "_at" to the corresponding Gene-
CardsIDs. Custom CDF, probe and annotation
Bioconductor libraries, fully compliant with Affymetrix
standards, have been constructed using dedicated func-
tions based on R and Bioconductor packages. As such,
Bioconductor users can easily take advantage of these
libraries, e.g., replacing, in AffyBatch objects, the values of
"cdfName" and "annotation" slots (supplementary infor-
mation). Moreover, GeneAnnot CDF can also be used
with all third-party software adopting Affymetrix stand-
ards, e.g., dChip.
Results
The quality of GeneAnnot custom CDFs was tested and
compared with other CDF files on the same experiment
used by Dai and co-workers to assess the impact of
probeset definition on the differential expression. The
data set is available at Gene Expression Omnibus GSE974
and consists of paired HG-U133A arrays hybridized with
RNA from the heart tissue of 19 patients with heart failure.
Samples were obtained at the implant and then at the
explant of a left ventricular assistant device. We compared
results obtained applying a standard analytical approach
on gene expression data generated using six different CDF
packages, specifically i) Bio_CDF, the Biocore hgu133acdf
library obtained from [13]; ii) Entrez8_CDF, based on
EntrezGene database and iii) RefSeq8_CDF, based on Ref-
Seq (CDF version 8 from Dai et al. [6], available at [9]);
iv) AV_CDF, based on AceView database (CDF version
1.12.0 from Lu et al. [7], available at [14]); v) GA6_CDF
and vi) GA11_CDF, the custom CDFs derived from Gene-
Annot and containing meta-probesets composed of at
least 6 and 11 probes per gene, respectively [15].
Probeset level data was generated through RMA with
default parameters and analyzed using SAM with the
paired data method in the R environment. According to
the procedure adopted by Dai et al. [6], lists of differen-
tially expressed genes (DEG) showing at least a 20%
change (i.e., fold change of at least 1.2) were generated at
SAM q-value thresholds of 1, 5, and 10%. Results
obtained using the various CDF files at the different q-
value thresholds are reported in Table 1. Regardless of
chip definition file and q-value cut-offs, the total number
of DEG is quite stable when utilizing different CDFs, espe-
cially at more stringent thresholds, and normally from 20
to 40% of DEG identified using Bio_CDF are not included
in DEG obtained with custom CDFs. Similarly, pair-wise
comparisons of the differentially expressed genes
obtained with the various CDFs indicate that about 30%
of the DEGs identified using a CDF cannot be confirmed
by the analysis based on another definition file. This evi-
dence is in accordance with the result from Dai et al. [6]
that, on average, about 40% DEG found with a CDF can-
not be confirmed by the others. The pair-wise compari-
sons among Entrez8_CDF andRefSeq8_CDF presented by
Dai et al. [6] and GeneAnnot CDFs indicate that the two
approaches produce definition files which generate the
most comparable results (on average 82% of commonly
identified DEG).
Discussion
A novel set of custom CDF and the corresponding Biocon-
ductor libraries for Affymetrix human 3' expression arrays
has been developed based on GeneAnnot and GeneCards
information. GeneCards is a popular and widely used
database integrating gene-centered information from
major databases, which could show some inconsistencies
among themselves if considered singularly. GeneAnnot
based CDFs are provided with libraries compliant with
Bioconductor standards, including probe libraries that are
required for sequence level analysis, such as GCRMA pre-
processing, and annotation libraries that take advantageBMC Bioinformatics 2007, 8:446 http://www.biomedcentral.com/1471-2105/8/446
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of the rich annotations that are reported in GeneCards,
thus facilitating their implementation by final users.
GeneAnnot custom CDFs address the problem of a relia-
ble reconstruction of expression signals through the inclu-
sion in a unique custom-probeset of only those probes
matching transcripts associated to a single gene. Different
groups in recent years have proposed a variety of methods
to re-define probesets from Affymetrix 3' arrays referring
to several databases and proposing different strategies to
solve the technical issues of probeset composition and
matching [6,7]. Each approach has advantages and disad-
vantages, although the definition of custom-probesets has
little effect on the general performance and the results of
sample clustering and classification [7,16]. Thus, the deci-
sion on which is the most appropriate custom-CDF to be
used, largely depends on the goals of the experimenter: if
the major purpose of the study is to analyze samples
based on the expression patterns, using either probeset
definition leads to similar results. When the focus comes
down to the identification of specific genes, then the most
appropriate CDF has to be carefully selected considering
issues related to the database and the strategy used to
group probe pairs into custom-probesets. Specifically, if
the biological relevancy is in detecting differentially
expressed genes, using custom CDFs which refer to gene-
centered database and combine all probes per gene into a
single probeset may be the best choice. On the other
hand, if the focus is distinguishing expression of individ-
ual transcript variants, then relying on a transcript-centered
database and sub-dividing probesets into small groups of
probes (e.g., 4–5 probes) covering individual exons may
be a more appropriate approach. GeneAnnot and
GA_CDFs have been proposed for improving the reliabil-
ity of results from gene-centered  analysis of microarray
experiments. In this regards, they aimed at eliminating the
presence of more than one probeset per gene, a frequent
instance in Affymetrix standard probeset definitions
which often leads to discordant expression signals when
the focus of the analysis is detecting differentially
expressed genes. Consequently, GA_CDFs may not repre-
sent the CDFs of choice when 3' expression arrays are used
to detect transcript variants, alternative splicing and exon
differential expression.
Using different CDFs directly reflects on different utiliza-
tion of the probe-level information available in the chip
for signal reconstruction. Expression data generated using
the Bio_CDF are based on all probes (100%) contained in
the chip while data obtained with the Entrez8_CDF rely
Table 1: Differentially expressed genes selected using different CDFs.
CDF type Number 
of DEG




Bio 42 17 40.5 Entrez8 RefSeq8 AceView GA6 GA11
Entrez8 28 60.7 Bio 25 29 22 33 33
RefSeq8 34 50 Entrez8 25 20 28 28
AceView 35 48.6 RefSeq8 22 29 29
GA6 46 37 AceView 23 23
GA11 42 40.5 GA6 42
q-value < 5%
Bio 76 42 55.3 Entrez8 RefSeq8 AceView GA6 GA11
Entrez8 99 42.4 Bio 51 54 52 56 54
RefSeq8 88 47.7 Entrez8 82 64 92 86
AceView 92 45.7 RefSeq8 63 82 77
GA6 109 38.5 AceView 66 63
GA11 99 42.4 GA6 99
q-value < 10%
Bio 140 73 52.1 Entrez8 RefSeq8 AceView GA6 GA11
Entrez8 125 58.4 Bio 89 94 97 100 96
RefSeq8 125 58.4 Entrez8 112 90 111 106
AceView 129 56.6 RefSeq8 94 109 103
GA6 139 52.5 AceView 93 89
GA11 130 56.2 GA6 129
Results from samr analysis of GSE974 dataset using six different CDFs under different q-value cut-offs in terms of number of total identified 
differentially expressed genes (DEG), of number and percentage of DEG in common by all lists generated using the various CDFs, and of number of 
DEG present in the pair-wise comparison of lists generated using different CDFs. EntrezGene IDs were used as reference identifiers to verify 
overlap of lists.BMC Bioinformatics 2007, 8:446 http://www.biomedcentral.com/1471-2105/8/446
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on the 68.7%. Similarly, AV_CDF accounts for 77.3% of
all probes when considering probesets with at least 4
probes [7]. In the latter case, indeed, 48% of probesets
have less than 4 probes and therefore may not support
reliable statistical summarization, as assessed by Lu et
coworkers [7]. Consequently, undesired probesets with
less than 4 probes should be filtered out before pre-
processing procedures, such as RMA, and this filtering
could be not trivial for final users. GA11_CDF has been
constructed using more than 77.5% of the probe-level
information and all custom-probesets include at least 11
probes, i.e. the minimum number of probes in the stand-
ard Affymetrix probesets. As discussed in [6] and [7], a
probeset composed of at least four probe pairs should sat-
isfy the minimum requirements of most probe-level anal-
ysis algorithms and, thus, any choice on the number of
probes composing a custom-probeset is largely arbitrary.
We imposed that each custom-probeset be represented by
at least 11 probes because in our GeneAnnot-based
probesets definition 90% of GeneCardsIDs are interro-
gated by custom-probesets composed of at least 11 probe
pairs (supplementary information). Nevertheless, the
functions to create the custom-probesets are generally
applicable and the minimum number of probe pairs mak-
ing up a custom-probeset is a tunable parameter. A com-
parison between the lists of differentially expressed genes
obtained using GA11_CDF and a GeneAnnot custom CDF
with probesets composed of 6 probe pairs (GA6_CDF,
accounting for 95% of GeneCardsIDs) indicates that the
impact of this parameter is minimal (Table 1).
The various CDFs result in different number of genes
whose transcripts levels are measured by a probeset or by
groups of probesets. In particular, the Bio_CDF contains
probesets associated to 13,389 EntrezGenes, while the
Entrez8_CDF accounts for 11,999 EntrezGenes.
GA6_CDF and GA11_CDF custom-probesets are anno-
tated to 12,074 and 11,408 EntrezGenes respectively, thus
representing comparable number of annotated genes
when compared with other gene-centered custom CDFs.
In addition, the deviation from the one-to-one probeset/
gene match is variable in the different definition files, due
both to the existence of multiple probesets per gene (or
multiple probesets per transcript as in AV_CDF) [8] or to
the presence of the same probe in multiple custom-
probesets, that adds ambiguity in the evaluation of signals
(e.g. in the RefSeq8_CDF probes with indexes 182067,
182068, 204881, and 204883 are present in 39 different
custom-probesets). On the contrary, GeneAnnot based
custom-probesets include only probes matching tran-
scripts linked to a single gene. As such, they preserve a
one-to-one correspondence between genes and custom-
probesets. Furthermore, each probe is assigned to a
unique custom-probeset, thus avoiding additional noise
due to the use of a probe into multiple probesets.
Finally, the reported data show that, when applied to the
analysis of a standard experimental design, GA_CDFs per-
form similarly to the other custom CDFs, with the addi-
tional advantage that GeneAnnot based CDFs are
provided with complete annotation libraries compliant
with Bioconductor standards, thus allowing an easier
implementation by final users.
Conclusion
This work present a novel set of custom CDFs for Affyme-
trix human GeneChips, based on GeneAnnot and Gene-
Cards. Although other alternative CDFs have been
recently released, GeneAnnot based custom CDFs consti-
tute a valuable alternative to Affymetrix and custom Chip
Definition Files since i) they are based on GeneCards, an
extensively-used database integrating information from
different sources; ii) address the problem of multiple
probesets per gene as well as the problem of probes
matching different genes within the same probeset; iii)
exploit an high percentage of the GeneChips probes, and
iv) could be easily adopted by final user since they are pro-
vided with Bioconductor-compliant libraries, including
probe and annotations libraries, that will be continuously
updated according with novel GeneAnnot and GeneCards
releases.
Availability and requirements
Project name: GeneAnnot custom CDF files
Project home pages: http://www.xlab.unimo.it/GA_CDF
and http://bioinfo2.weizmann.ac.il/geneannot/custom
cdf.html
Operating systems: platform independent
Programming language: R scripting language
Other requirements: R statistical environment 2.4 or
higher and Bioconconductor 1.9 or higher are required to
use Bioconductor-compliant packages. Standalone CDF
files can be used with any software adopting Affymetrix
standards for CDF files.
License: GPL
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